Form 4: GeneDx Holdings Corp. Executive Receives Restricted Stock Units

Bryan Dechairo, Chief Operating Officer of GeneDx Holdings Corp., was granted 37,497 restricted stock units (RSUs) on January 14, 2025.

Summary

• Bryan Dechairo, the Chief Operating Officer of GeneDx Holdings Corp., received 37,497 restricted stock units (RSUs) on January 14, 2025.
• Each RSU represents the right to receive one share of the company's Class A Common Stock upon vesting.
• The RSUs will vest in equal monthly installments over four years, starting on February 1, 2026, contingent on Dechairo's continued employment with the company.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management interests with shareholders. There are no negative implications.

Positives

• The grant of RSUs aligns the executive's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the executive.

Risks

• The value of the RSUs is dependent on the future performance of GeneDx's stock price.
• The executive must remain employed with the company to fully vest the RSUs.

Future Outlook

The executive will receive shares of Class A Common Stock as the RSUs vest over the next four years, contingent on continued employment.

Industry Context

The granting of restricted stock units is a common practice in the biotechnology industry to incentivize and retain key executives.

Comparison to Industry Standards

• Many biotechnology companies use stock-based compensation, such as RSUs, to attract and retain talent.
• The vesting schedule of four years is fairly standard for executive RSU grants.
• Companies like Illumina, Inc. and Exact Sciences Corp. also use similar equity-based compensation plans for their executives.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it incentivizes the executive to improve company performance.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Next Steps

• The executive will continue to vest in the RSUs over the next four years, subject to continued employment.

Key Dates

Keywords

Restricted Stock Units, RSU, GeneDx Holdings Corp, Bryan Dechairo, Executive Compensation, Stock Options, Vesting